Oxford BioMedica plc (LON:OXB) insider Lorenzo Tallarigo acquired 22,066 shares of the business’s stock in a transaction dated Thursday, March 22nd. The shares were purchased at an average price of GBX 12 ($0.17) per share, with a total value of £2,647.92 ($3,658.36).
Lorenzo Tallarigo also recently made the following trade(s):
- On Friday, February 23rd, Lorenzo Tallarigo acquired 22,121 shares of Oxford BioMedica stock. The shares were purchased at an average price of GBX 12 ($0.17) per share, with a total value of £2,654.52 ($3,667.48).
OXB stock opened at GBX 11.30 ($0.16) on Friday. Oxford BioMedica plc has a 12-month low of GBX 4.44 ($0.06) and a 12-month high of GBX 13.19 ($0.18).
About Oxford BioMedica
Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company’s segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners.
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.